Basecamp Bio develops cell and gene therapies using proprietary technologies such as gene editing, RNA engineering, and viral delivery systems to create effective treatments for various diseases. The company addresses the need for efficient manufacturing and development processes in the regenerative medicine sector, enabling faster access to life-saving therapies.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MCFounders
Product
Problem
The development and manufacturing of cell and gene therapies often face significant hurdles, including inefficient processes, scalability challenges, and limited access to advanced technologies, which can delay the availability of life-saving treatments. Traditional methods struggle to keep pace with the rapidly evolving landscape of regenerative medicine, hindering the efficient translation of research breakthroughs into clinical applications.
Solution
ElevateBio is a technology-driven company focused on accelerating the development and manufacturing of cell and gene therapies. They offer end-to-end capabilities, technology platforms, and therapeutic approaches all under one roof, streamlining the entire process from concept to commercialization. By integrating manufacturing expertise, next-generation technologies, and therapeutic development, ElevateBio aims to overcome the bottlenecks that traditionally slow down the delivery of genetic medicines. Their ecosystem fosters innovation and removes barriers to knowledge, enabling partners to develop and manufacture transformative therapies at an accelerated pace.
Target Audience
ElevateBio primarily serves industry and academic partners involved in the development of cell and gene therapies, including biotech companies, research institutions, and pharmaceutical organizations.
Features
- End-to-end cGMP manufacturing and automation capabilities for cell and gene therapies
- Proprietary technology platforms including gene editing, cell therapy enabling technologies, and RNA, protein & vector engineering
- Development of both _ex vivo_ and _in vivo_ cell and gene therapies
- BaseCamp® facilities offering state-of-the-art manufacturing for genetic medicines
- LentiPeak™ lentiviral vector platform for efficient viral vector production
- Life Edit CRISPR systems and Adenine Deaminases for advanced gene editing
- Integrated ecosystem for discovery, development, manufacturing, and commercialization